MicroRNA-30 inhibits neointimal hyperplasia by targeting Ca(2+)/calmodulin-dependent protein kinase IIδ (CaMKIIδ).

Saved in:

Bibliographic Details
Title:	MicroRNA-30 inhibits neointimal hyperplasia by targeting Ca(2+)/calmodulin-dependent protein kinase IIδ (CaMKIIδ).
Authors:	Liu YF; From the Center for Cardiovascular Sciences, Albany Medical College, Albany, NY (USA)., Spinelli A; From the Center for Cardiovascular Sciences, Albany Medical College, Albany, NY (USA)., Sun LY; From the Center for Cardiovascular Sciences, Albany Medical College, Albany, NY (USA)., Jiang M; From the Center for Cardiovascular Sciences, Albany Medical College, Albany, NY (USA)., Singer DV; From the Center for Cardiovascular Sciences, Albany Medical College, Albany, NY (USA)., Ginnan R; From the Center for Cardiovascular Sciences, Albany Medical College, Albany, NY (USA)., Saddouk FZ; From the Center for Cardiovascular Sciences, Albany Medical College, Albany, NY (USA)., Van Riper D; From the Center for Cardiovascular Sciences, Albany Medical College, Albany, NY (USA)., Singer HA; From the Center for Cardiovascular Sciences, Albany Medical College, Albany, NY (USA).
Source:	Scientific reports [Sci Rep] 2016 May 20; Vol. 6, pp. 26166. Date of Electronic Publication: 2016 May 20.
Publication Type:	Journal Article; Research Support, N.I.H., Extramural
Journal Info:	Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2045-2322
DOI:	10.1038/srep26166